Transactivation of EGFR by LPS induces COX-2 expression in enterocytes.

PubWeight™: 0.99‹?› | Rank: Top 15%

🔗 View Article (PMC 3364993)

Published in PLoS One on May 31, 2012

Authors

Steven J McElroy1, Stuart Hobbs, Michael Kallen, Noemi Tejera, Michael J Rosen, Anatoly Grishin, Poojitha Matta, Claus Schneider, Jeffrey Upperman, Henri Ford, D Brent Polk, Jörn-Hendrik Weitkamp

Author Affiliations

1: Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.

Articles citing this

EGFR has a tumour-promoting role in liver macrophages during hepatocellular carcinoma formation. Nat Cell Biol (2014) 1.16

Mechanisms of gut barrier failure in the pathogenesis of necrotizing enterocolitis: Toll-like receptors throw the switch. Semin Pediatr Surg (2013) 0.98

Tyrosine phosphorylation in Toll-like receptor signaling. Cytokine Growth Factor Rev (2014) 0.90

Erlotinib protects against LPS-induced endotoxicity because TLR4 needs EGFR to signal. Proc Natl Acad Sci U S A (2015) 0.82

Advanced glycation end-products induce apoptosis in pancreatic islet endothelial cells via NF-κB-activated cyclooxygenase-2/prostaglandin E2 up-regulation. PLoS One (2015) 0.81

Icariside II activates EGFR-Akt-Nrf2 signaling and protects osteoblasts from dexamethasone. Oncotarget (2016) 0.80

Sphingosine 1-phosphate (S1P) induced interleukin-8 (IL-8) release is mediated by S1P receptor 2 and nuclear factor κB in BEAS-2B cells. PLoS One (2014) 0.79

Squamosamide derivative FLZ protects retinal pigment epithelium cells from oxidative stress through activation of epidermal growth factor receptor (EGFR)-AKT signaling. Int J Mol Sci (2014) 0.79

c-KIT signaling is targeted by pathogenic Yersinia to suppress the host immune response. BMC Microbiol (2013) 0.78

Induction of COX-2-PGE2 synthesis by activation of the MAPK/ERK pathway contributes to neuronal death triggered by TDP-43-depleted microglia. Cell Death Dis (2015) 0.78

Effect of bowel resection on TLR signaling during intestinal adaptation in a rat model. Surg Endosc (2016) 0.76

Exoming into rare skin disease: EGFR deficiency. J Invest Dermatol (2014) 0.76

Helicobacter pylori-induced gastric mucosal TGF-α ectodomain shedding and EGFR transactivation involves Rac1/p38 MAPK-dependent TACE activation. Inflammopharmacology (2015) 0.76

Renal cortical hexokinase and pentose phosphate pathway activation through the EGFR/Akt signaling pathway in endotoxin-induced acute kidney injury. Am J Physiol Renal Physiol (2014) 0.76

Are EGF and TLR-4 crucial to understanding the link between milk and NEC? Mucosal Immunol (2015) 0.75

Staurosporine synergistically potentiates the deoxycholate-mediated induction of COX-2 expression. Physiol Rep (2014) 0.75

Role of LPS-elicited signaling in triggering gastric mucosal inflammatory responses to H. pylori: modulatory effect of ghrelin. Inflammopharmacology (2017) 0.75

Articles cited by this

Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics (2010) 9.15

Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol (2007) 6.68

Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature (1995) 4.56

Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology (2007) 3.99

Necrotising enterocolitis. Lancet (2006) 3.94

The roles of bacteria and TLR4 in rat and murine models of necrotizing enterocolitis. J Immunol (2006) 2.83

Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine. Gastroenterology (2006) 2.78

A critical role for TLR4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair. J Immunol (2007) 2.77

Toll-like receptor-4 inhibits enterocyte proliferation via impaired beta-catenin signaling in necrotizing enterocolitis. Gastroenterology (2009) 2.64

Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. J Clin Invest (1996) 2.31

Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2. J Clin Invest (2000) 2.27

Necrotizing enterocolitis among neonates in the United States. J Perinatol (2003) 2.24

Mortality of necrotizing enterocolitis expressed by birth weight categories. J Pediatr Surg (2009) 1.90

Reciprocal expression and signaling of TLR4 and TLR9 in the pathogenesis and treatment of necrotizing enterocolitis. J Immunol (2009) 1.83

Intestinal barrier failure during experimental necrotizing enterocolitis: protective effect of EGF treatment. Am J Physiol Gastrointest Liver Physiol (2006) 1.83

Ontogeny of salivary epidermal growth factor and necrotizing enterocolitis. J Pediatr (2007) 1.75

Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model. Am J Physiol Gastrointest Liver Physiol (2002) 1.75

Transactivation of EGF receptor and ErbB2 protects intestinal epithelial cells from TNF-induced apoptosis. Proc Natl Acad Sci U S A (2008) 1.58

Endotoxin inhibits intestinal epithelial restitution through activation of Rho-GTPase and increased focal adhesions. J Biol Chem (2004) 1.49

No longer an innocent bystander: epithelial toll-like receptor signaling in the development of mucosal inflammation. Mol Med (2008) 1.46

Toll-like receptor 4 differentially regulates epidermal growth factor-related growth factors in response to intestinal mucosal injury. Lab Invest (2010) 1.23

Pseudomonas lipopolysaccharide accelerates wound repair via activation of a novel epithelial cell signaling cascade. J Immunol (2006) 1.22

Current concepts regarding the pathogenesis of necrotizing enterocolitis. Pediatr Surg Int (2009) 1.21

Lipopolysaccharide induces cyclooxygenase-2 in intestinal epithelium via a noncanonical p38 MAPK pathway. J Immunol (2006) 1.07

Epidermal growth factor reduces autophagy in intestinal epithelium and in the rat model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol (2010) 1.06

Ileal cytokine dysregulation in experimental necrotizing enterocolitis is reduced by epidermal growth factor. J Pediatr Gastroenterol Nutr (2003) 1.06

Molecular mechanisms contributing to necrotizing enterocolitis. Ann Surg (2001) 1.05

Diminished epidermal growth factor levels in infants with necrotizing enterocolitis. J Pediatr Surg (2000) 0.96

p38 MAP kinase mediates endotoxin-induced expression of cyclooxygenase-2 in enterocytes. Surgery (2004) 0.91

Role of epidermal growth factor and other growth factors in the prevention of necrotizing enterocolitis. Semin Perinatol (2008) 0.89

Molecular signaling in necrotizing enterocolitis: regulation of intestinal COX-2 expression. J Pediatr Surg (2007) 0.89

Ontogeny of EGF receptors in the human gut. Front Biosci (1999) 0.88

Immunoreactive epidermal growth factor receptors are present in gastrointestinal epithelial cells of preterm infants with necrotising enterocolitis. Early Hum Dev (2001) 0.83

Articles by these authors

Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology (2006) 3.96

Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor. J Clin Endocrinol Metab (2004) 2.72

En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients. Ann Surg (2008) 2.64

Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J Biol Chem (2002) 2.59

Recovery after open versus laparoscopic pyloromyotomy for pyloric stenosis: a double-blind multicentre randomised controlled trial. Lancet (2009) 2.51

Effects of interleukin-2 plus highly active antiretroviral therapy on HIV-1 replication and proviral DNA (COSMIC trial). AIDS (2002) 2.40

Major complications associated with xenograft biologic mesh implantation in abdominal wall reconstruction. Surg Innov (2009) 2.37

Recurrent abdominal pain: symptom subtypes based on the Rome II Criteria for pediatric functional gastrointestinal disorders. J Pediatr Gastroenterol Nutr (2004) 2.26

Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism. J Clin Invest (2011) 2.16

Modified hernia grading scale to stratify surgical site occurrence after open ventral hernia repairs. J Am Coll Surg (2012) 2.07

Enterocyte TLR4 mediates phagocytosis and translocation of bacteria across the intestinal barrier. J Immunol (2006) 2.06

Transversus abdominis muscle release: a novel approach to posterior component separation during complex abdominal wall reconstruction. Am J Surg (2012) 2.06

Permissible Intraabdominal Hypertension following Complex Abdominal Wall Reconstruction. Plast Reconstr Surg (2015) 2.00

A primer on natural orifice transluminal endoscopic surgery: building a new paradigm. Surg Innov (2006) 1.93

Outcomes of synthetic mesh in contaminated ventral hernia repairs. J Am Coll Surg (2013) 1.89

Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC- and MAP kinase-dependent mechanism. Am J Physiol Gastrointest Liver Physiol (2008) 1.83

Resection vs drainage in treatment of chronic pancreatitis: long-term results of a randomized trial. Gastroenterology (2008) 1.75

Intracranial pressure monitoring in severe isolated pediatric blunt head trauma. Am Surg (2008) 1.60

Transactivation of EGF receptor and ErbB2 protects intestinal epithelial cells from TNF-induced apoptosis. Proc Natl Acad Sci U S A (2008) 1.58

Responsible development and application of surgical innovations: a position statement of the Society of University Surgeons. J Am Coll Surg (2008) 1.55

Regulation of apoptosis during homeostasis and disease in the intestinal epithelium. Inflamm Bowel Dis (2006) 1.51

Expansion of pre-existing, lymph node-localized CD8+ T cells during supervised treatment interruptions in chronic HIV-1 infection. J Clin Invest (2002) 1.50

Tumor necrosis factor regulates intestinal epithelial cell migration by receptor-dependent mechanisms. Am J Physiol Cell Physiol (2002) 1.50

Use of acellular dermal matrix for complicated ventral hernia repair: does technique affect outcomes? J Am Coll Surg (2007) 1.48

Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases. Inflamm Bowel Dis (2008) 1.45

Human peritoneal membrane reduces the formation of intra-abdominal adhesions in ventral hernia repair: experimental study in a chronic hernia rat model. J Surg Res (2009) 1.43

Increased expression and function of integrins in enterocytes by endotoxin impairs epithelial restitution. Gastroenterology (2005) 1.43

Spermine oxidase mediates the gastric cancer risk associated with Helicobacter pylori CagA. Gastroenterology (2011) 1.41

Epidermal growth factor stimulates Rac activation through Src and phosphatidylinositol 3-kinase to promote colonic epithelial cell migration. Am J Physiol Gastrointest Liver Physiol (2007) 1.40

Kinase suppressor of Ras-1 protects intestinal epithelium from cytokine-mediated apoptosis during inflammation. J Clin Invest (2004) 1.40

Characterization of a probiotic-derived soluble protein which reveals a mechanism of preventive and treatment effects of probiotics on intestinal inflammatory diseases. Gut Microbes (2012) 1.40

Long-term follow-up of a randomized trial comparing the beger and frey procedures for patients suffering from chronic pancreatitis. Ann Surg (2005) 1.37

Integrin alpha1beta1 controls reactive oxygen species synthesis by negatively regulating epidermal growth factor receptor-mediated Rac activation. Mol Cell Biol (2007) 1.37

p38 kinase regulates epidermal growth factor receptor downregulation and cellular migration. EMBO J (2006) 1.36

Cysteine-rich domains of muc3 intestinal mucin promote cell migration, inhibit apoptosis, and accelerate wound healing. Gastroenterology (2006) 1.33

Epidermal growth factor-stimulated intestinal epithelial cell migration requires Src family kinase-dependent p38 MAPK signaling. J Biol Chem (2004) 1.32

Helicobacter pylori regulates cellular migration and apoptosis by activation of phosphatidylinositol 3-kinase signaling. J Infect Dis (2009) 1.29

Risk of early surgery for Crohn's disease: implications for early treatment strategies. Am J Gastroenterol (2003) 1.29

Commensal bacteria in the gut: learning who our friends are. Curr Opin Gastroenterol (2004) 1.29

The ErbB4 growth factor receptor is required for colon epithelial cell survival in the presence of TNF. Gastroenterology (2008) 1.29

Epidermal growth factor receptor activation protects gastric epithelial cells from Helicobacter pylori-induced apoptosis. Gastroenterology (2009) 1.28

Laparoscopic approach to treatment of sigmoid diverticulitis: changes in the spectrum of indications and results of a prospective, multicenter study on 1,545 patients. Dis Colon Rectum (2004) 1.27

Disordered enterocyte signaling and intestinal barrier dysfunction in the pathogenesis of necrotizing enterocolitis. Semin Pediatr Surg (2005) 1.26

Laparoscopic versus open inguinal hernia repair. Surg Clin North Am (2013) 1.25

Probiotics as functional food in the treatment of diarrhea. Curr Opin Clin Nutr Metab Care (2006) 1.24

The lipoxygenase gene ALOXE3 implicated in skin differentiation encodes a hydroperoxide isomerase. Proc Natl Acad Sci U S A (2003) 1.22

Current concepts regarding the pathogenesis of necrotizing enterocolitis. Pediatr Surg Int (2009) 1.21

Inpatient mortality analysis of paraesophageal hernia repair in octogenarians. J Gastrointest Surg (2008) 1.20

A comprehensive model of positional and stereo control in lipoxygenases. Biochem Biophys Res Commun (2005) 1.20

Low levels of tumor necrosis factor alpha increase tumor growth by inducing an endothelial phenotype of monocytes recruited to the tumor site. Cancer Res (2009) 1.17

Nitric oxide inhibits enterocyte migration through activation of RhoA-GTPase in a SHP-2-dependent manner. Am J Physiol Gastrointest Liver Physiol (2007) 1.16

Functional analysis of the p40 and p75 proteins from Lactobacillus casei BL23. J Mol Microbiol Biotechnol (2010) 1.16

Open ventral hernia repair with component separation. Surg Clin North Am (2013) 1.15

Endoscopic versus open component separation in complex abdominal wall reconstruction. Am J Surg (2010) 1.14

Microcirculatory function and tissue damage is improved after therapeutic injection of bovine hemoglobin in severe acute rodent pancreatitis. Pancreas (2005) 1.14

Natural orifice transluminal endoscopic surgery (NOTES) as a diagnostic tool in the intensive care unit. Surg Endosc (2007) 1.14

STAT6 activation in ulcerative colitis: a new target for prevention of IL-13-induced colon epithelial cell dysfunction. Inflamm Bowel Dis (2011) 1.13

Autoxidative and cyclooxygenase-2 catalyzed transformation of the dietary chemopreventive agent curcumin. J Biol Chem (2010) 1.13

Berberine promotes recovery of colitis and inhibits inflammatory responses in colonic macrophages and epithelial cells in DSS-treated mice. Am J Physiol Gastrointest Liver Physiol (2011) 1.12

A 49-kDa mini-lipoxygenase from Anabaena sp. PCC 7120 retains catalytically complete functionality. J Biol Chem (2007) 1.12

Evidence for an ionic intermediate in the transformation of fatty acid hydroperoxide by a catalase-related allene oxide synthase from the Cyanobacterium Acaryochloris marina. J Biol Chem (2009) 1.12

The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride. J Am Acad Dermatol (2006) 1.12

Berberine induces caspase-independent cell death in colon tumor cells through activation of apoptosis-inducing factor. PLoS One (2012) 1.12

The biology of biologics: basic science and clinical concepts. Plast Reconstr Surg (2012) 1.11

L1 is associated with micrometastatic spread and poor outcome in colorectal cancer. Mod Pathol (2007) 1.10

On the relationships of substrate orientation, hydrogen abstraction, and product stereochemistry in single and double dioxygenations by soybean lipoxygenase-1 and its Ala542Gly mutant. J Biol Chem (2005) 1.10

Peroxynitrite inhibits enterocyte proliferation and modulates Src kinase activity in vitro. Am J Physiol Gastrointest Liver Physiol (2003) 1.10

Induction of apoptosis in colorectal carcinoma cells treated with 4-hydroxy-2-nonenal and structurally related aldehydic products of lipid peroxidation. Chem Res Toxicol (2004) 1.08

L-arginine supplementation improves responses to injury and inflammation in dextran sulfate sodium colitis. PLoS One (2012) 1.08

Formation of 4-hydroxynonenal from cardiolipin oxidation: Intramolecular peroxyl radical addition and decomposition. Free Radic Biol Med (2010) 1.08

Bmp signaling is required for intestinal growth and morphogenesis. Dev Dyn (2006) 1.07

Pure natural orifice transluminal endoscopic surgery (NOTES) nephrectomy using standard laparoscopic instruments in the porcine model. J Endourol (2008) 1.06

Necrotising enterocolitis is characterised by disrupted immune regulation and diminished mucosal regulatory (FOXP3)/effector (CD4, CD8) T cell ratios. Gut (2012) 1.06

The GHESKIO refugee camp after the earthquake in Haiti--dispatch 2 from Port-au-Prince. N Engl J Med (2010) 1.06

Tumor necrosis factor receptor 1-dependent depletion of mucus in immature small intestine: a potential role in neonatal necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol (2011) 1.06

The hepoxilin connection in the epidermis. FEBS J (2007) 1.05

Raf protects against colitis by promoting mouse colon epithelial cell survival through NF-kappaB. Gastroenterology (2008) 1.05

Evaluation of the efficacy of the electrosurgical bipolar vessel sealer (LigaSure) devices in sealing lymphatic vessels. Surg Innov (2005) 1.03

The role of nitric oxide in intestinal epithelial injury and restitution in neonatal necrotizing enterocolitis. Semin Perinatol (2008) 1.03

Antibiotic-releasing mesh coating to reduce prosthetic sepsis: an in vivo study. J Surg Res (2010) 1.02

Oxidative metabolites of curcumin poison human type II topoisomerases. Biochemistry (2012) 1.02

Epidermal growth factor receptor inhibits colitis-associated cancer in mice. J Clin Invest (2012) 1.01

Laparoscopic and hand-assisted distal pancreatectomy. Am Surg (2008) 1.01

Mechanisms of nitric oxide-mediated intestinal barrier failure in necrotizing enterocolitis. Semin Pediatr Surg (2005) 1.01

Carbon monoxide protects against the development of experimental necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol (2005) 1.01

Paneth cell ablation in the presence of Klebsiella pneumoniae induces necrotizing enterocolitis (NEC)-like injury in the small intestine of immature mice. Dis Model Mech (2012) 1.01

The timing of delivery of infants with gastroschisis influences outcome. J Pediatr Surg (2005) 1.00

Laparoscopic mechanical fixation devices: does firing angle matter? Surg Endosc (2013) 1.00

Fibroblast growth factor 10 is required for survival and proliferation but not differentiation of intestinal epithelial progenitor cells during murine colon development. Dev Biol (2006) 1.00

Acute appendicitis following colonoscopy. J Clin Gastroenterol (2005) 1.00

Teleassessment compared with live assessment of pressure ulcers in a wound clinic: a pilot study. Adv Skin Wound Care (2003) 0.98

Mapping the New World of Necrotizing Enterocolitis (NEC): Review and Opinion. EJ Neonatol Res (2012) 0.98

Vanillin and ferulic acid: not the major degradation products of curcumin. Trends Mol Med (2012) 0.98

Staged repair of massive incisional hernias with loss of abdominal domain: a novel approach. Am J Surg (2008) 0.97

Posterior and open anterior components separations: a comparative analysis. Am J Surg (2012) 0.97

Smad7 inhibits autocrine expression of TGF-β2 in intestinal epithelial cells in baboon necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol (2012) 0.97